TYGACIL

This brand name is authorized in United States. It is also authorized in Austria, Brazil, Canada, Croatia, Cyprus, Ecuador, Estonia, Finland, France, Hong Kong SAR China, Ireland, Israel, Italy, Japan, Lithuania, Mexico, Netherlands, New Zealand, Nigeria, Poland, Romania, Singapore, South Africa, Spain, Tunisia, Turkey, UK.

Active ingredients

The drug TYGACIL contains one active pharmaceutical ingredient (API):

1	Tigecycline UNII 70JE2N95KR - TIGECYCLINE
	Tigecycline, a glycylcycline antibiotic, inhibits protein translation in bacteria by binding to the 30S ribosomal subunit and blocking entry of amino-acyl tRNA molecules into the A site of the ribosome. This prevents incorporation of amino acid residues into elongating peptide chains.
	Read more about Tigecycline

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
TYGACIIL Powder for solution for infusion	MPI, EU: SmPC	European Medicines Agency (EU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
J01AA12	Tigecycline	J Antiinfectives for systemic use → J01 Antibacterials for systemic use → J01A Tetracyclines → J01AA Tetracyclines
Discover more medicines within J01AA12

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
BR	Câmara de Regulação do Mercado de Medicamentos	522710001153315
CA	Health Products and Food Branch	02285401
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	1858-MEE-0316
EE	Ravimiamet	1243695
ES	Centro de información online de medicamentos de la AEMPS	06336001
FI	Lääkealan turvallisuus- ja kehittämiskeskus	024024
FR	Base de données publique des médicaments	69265912
GB	Medicines & Healthcare Products Regulatory Agency	103211
HK	Department of Health Drug Office	54821
IL	מִשְׂרַד הַבְּרִיאוּת	6981
IT	Agenzia del Farmaco	037046012
JP	医薬品医療機器総合機構	6129400F1020
LT	Valstybinė vaistų kontrolės tarnyba	1031483
MX	Comisión Federal para la Protección contra Riesgos Sanitarios	492M2005
NG	Registered Drug Product Database	B4-0305
Switch country to Nigeria in order to find specific presentations of TYGACIL
NL	Z-Index G-Standaard, PRK	80500
NZ	Medicines and Medical Devices Safety Authority	12190
PL	Rejestru Produktów Leczniczych	100052956
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W64909001
SG	Health Sciences Authority	13282P
TN	Direction de la Pharmacie et du Médicament	8013161H, 8063141H
TR	İlaç ve Tıbbi Cihaz Kurumu	8681308791009
US	FDA, National Drug Code	0008-4990, 0008-4994
ZA	Health Products Regulatory Authority	A40/20.1.1/0230